Gencurix Inc. (229000.KQ)

KRW 1685.0

(3.44%)

Net Income Summary of Gencurix Inc.

  • Gencurix Inc.'s latest annual net income in 2023 was -19.26 Billion KRW , up 21.7% from previous year.
  • Gencurix Inc.'s latest quarterly net income in 2024 Q2 was -4.05 Billion KRW , down -25.38% from previous quarter.
  • Gencurix Inc. reported an annual net income of -24.59 Billion KRW in 2022, up 29.05% from previous year.
  • Gencurix Inc. reported an annual net income of -34.67 Billion KRW in 2021, down -204.72% from previous year.
  • Gencurix Inc. reported a quarterly net income of -4.05 Billion KRW for 2024 Q2, down -25.38% from previous quarter.
  • Gencurix Inc. reported a quarterly net income of -6.13 Billion KRW for 2023 Q1, down -71.87% from previous quarter.

Annual Net Income Chart of Gencurix Inc. (2023 - 2015)

Historical Annual Net Income of Gencurix Inc. (2023 - 2015)

Year Net Income Net Income Growth
2023 -19.26 Billion KRW 21.7%
2022 -24.59 Billion KRW 29.05%
2021 -34.67 Billion KRW -204.72%
2020 33.1 Billion KRW 461.36%
2019 -9.16 Billion KRW -60.05%
2018 -5.72 Billion KRW 16.06%
2017 -6.81 Billion KRW 24.76%
2016 -9.06 Billion KRW -127.63%
2015 -3.98 Billion KRW 0.0%

Peer Net Income Comparison of Gencurix Inc.

Name Net Income Net Income Difference
Osang Healthcare Co.,Ltd 116.43 Billion KRW 116.541%
InBody Co.,Ltd 36.72 Billion KRW 152.447%
Curexo Inc. -4.85 Billion KRW -296.622%
Seegene, Inc. 669.01 Million KRW 2978.876%
i-SENS, Inc. 3.7 Billion KRW 619.269%
Ray Co., Ltd. -2.14 Billion KRW -797.351%
Sugentech Inc. -17.23 Billion KRW -11.728%
L&C Bio Co., Ltd 48.36 Billion KRW 139.826%